Advanced interatrial block is a surrogate for left atrial strain reduction which predicts atrial fibrillation and stroke.


Journal

Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc
ISSN: 1542-474X
Titre abrégé: Ann Noninvasive Electrocardiol
Pays: United States
ID NLM: 9607443

Informations de publication

Date de publication:
07 2019
Historique:
received: 30 11 2018
accepted: 28 12 2018
pubmed: 6 2 2019
medline: 3 6 2020
entrez: 6 2 2019
Statut: ppublish

Résumé

The association between advanced interatrial block (aIAB) and atrial fibrillation (AF) is known as "Bayes' Syndrome." There is little information on the prognostic role that new speckle tracking echocardiographic (STE) imaging techniques could play in it. We have examined the relationship between left atrial (LA) STE and the prediction of new-onset AF and/or stroke in IAB patients. This is an observational prospective and unicentric cohort study with 98 outpatients: 55 (56.2%) controls with normal ECG without IAB, 21 (21.4%) with partial IAB (pIAB) and 22 (22.4%) with aIAB. The end point was new-onset AF, ischemic stroke and the composite of both. During a mean follow-up of 1.9 (1.7-2.3) years, 20 patients presented the end point (18 new-onset AF and two strokes): 8 (14.5%) in the control group, 3 (14.3%) in pIAB and 9 (40.9%) in aIAB, p = 0.03. In multivariable comprehensive Cox regression analyses, a decrease in absolute value of strain rate during the booster pump function phase (SRa) was the only variable independently related to the appearance in the evolution of the end point, in the first model (age, P-wave duration and SRa): HR 19.9 (95% CI, 3.12-127.5), p = 0.002 and in the second (age, presence of aIAB and SRa): HR 24.2 (95% CI, 3.15-185.4), p = 0.002. In patients with IAB, a decrease in absolute value of LA SRa with STE predicts new-onset AF and ischemic stroke. Future studies should confirm our results and assess the prognostic usefulness of LA STE in patients with IAB.

Sections du résumé

BACKGROUND
The association between advanced interatrial block (aIAB) and atrial fibrillation (AF) is known as "Bayes' Syndrome." There is little information on the prognostic role that new speckle tracking echocardiographic (STE) imaging techniques could play in it. We have examined the relationship between left atrial (LA) STE and the prediction of new-onset AF and/or stroke in IAB patients.
METHODS
This is an observational prospective and unicentric cohort study with 98 outpatients: 55 (56.2%) controls with normal ECG without IAB, 21 (21.4%) with partial IAB (pIAB) and 22 (22.4%) with aIAB. The end point was new-onset AF, ischemic stroke and the composite of both.
RESULTS
During a mean follow-up of 1.9 (1.7-2.3) years, 20 patients presented the end point (18 new-onset AF and two strokes): 8 (14.5%) in the control group, 3 (14.3%) in pIAB and 9 (40.9%) in aIAB, p = 0.03. In multivariable comprehensive Cox regression analyses, a decrease in absolute value of strain rate during the booster pump function phase (SRa) was the only variable independently related to the appearance in the evolution of the end point, in the first model (age, P-wave duration and SRa): HR 19.9 (95% CI, 3.12-127.5), p = 0.002 and in the second (age, presence of aIAB and SRa): HR 24.2 (95% CI, 3.15-185.4), p = 0.002.
CONCLUSIONS
In patients with IAB, a decrease in absolute value of LA SRa with STE predicts new-onset AF and ischemic stroke. Future studies should confirm our results and assess the prognostic usefulness of LA STE in patients with IAB.

Identifiants

pubmed: 30719798
doi: 10.1111/anec.12632
pmc: PMC6931526
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

e12632

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Références

Rev Esp Cardiol (Engl Ed). 2016 Apr;69(4):374-6
pubmed: 26944349
J Am Soc Echocardiogr. 2016 Apr;29(4):277-314
pubmed: 27037982
J Am Soc Echocardiogr. 2015 Jun;28(6):709-17
pubmed: 25704553
Rev Esp Cardiol (Engl Ed). 2017 Oct;70(10):841-847
pubmed: 28330820
Am J Cardiol. 2016 Jun 1;117(11):1755-9
pubmed: 27072646
BMC Cardiovasc Disord. 2018 Feb 21;18(1):38
pubmed: 29466939
Int J Cardiol. 2018 Nov 15;271:174-180
pubmed: 29801761
J Am Coll Cardiol. 2015 May 26;65(20):2239-51
pubmed: 25998669
Eur Heart J Cardiovasc Imaging. 2012 Mar;13(3):243-50
pubmed: 22120846
Ann Noninvasive Electrocardiol. 2019 Jul;24(4):e12632
pubmed: 30719798
Eur Heart J Cardiovasc Imaging. 2015 Sep;16(9):1008-14
pubmed: 25750193
Eur Heart J. 1988 Oct;9(10):1112-8
pubmed: 3208776
Heart Rhythm. 2015 Jan;12(1):11-8
pubmed: 25172009
Expert Rev Cardiovasc Ther. 2015 May;13(5):541-50
pubmed: 25907617
Circulation. 2007 Mar 13;115(10):1306-24
pubmed: 17322457
J Am Soc Echocardiogr. 2015 Jan;28(1):1-39.e14
pubmed: 25559473
J Am Soc Echocardiogr. 2009 Mar;22(3):299-305
pubmed: 19258177

Auteurs

Juan Lacalzada-Almeida (J)

Department of Cardiology, Hospital Universitario de Canarias, Tenerife, Spain.

María Manuela Izquierdo-Gómez (MM)

Department of Cardiology, Hospital Universitario de Canarias, Tenerife, Spain.

Javier García-Niebla (J)

Servicios Sanitarios del Área de Salud de El Hierro, Valle del Golfo Health Center, El Hierro, Spain.

Roberto Elosua (R)

Cardiovascular Epidemiology and Genetics Research Group, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Catalonia, Spain.
Facultad de Medicina, CIBER Cardiovascular Diseases (CIBERCV), Universidad de Vic-Central de Cataluña, Vic, Spain.

Alejandro Jiménez-Sosa (A)

Research Unit, Hospital Universitario de Canarias, La Laguna, Santa Cruz de Tenerife, Spain.

Adrian Baranchuk (A)

Heart Rhythm Service, Kingston General Hospital, Queen's University, Kingston, Ontario, Canada.

Antonio Bayes de Luna (A)

Fundación Investigación Cardiovascular, Institut Català Ciències Cardiovasculars, Barcelona, Catalonia, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH